SHP-141C in Plaque Type Psoriasis

Clinical trial NCT01646567 · COMPLETED

Trial details

NCT number: NCT01646567
Sponsor: TetraLogic Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plaque Type Psoriasis

Start date: 2012-09-01
Primary completion: 2012-11-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.